Merck begins late-stage trial of experimental Covid-19 drug

Reuters

01 September, 2021, 05:00 pm

Last modified: 01 September, 2021, 05:03 pm

FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Linden, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermid/File Photo

Merck & Co Inc and partner Ridgeback Biotherapeutics said on Wednesday they had begun enrolling patients in a late-stage trial of their experimental drug molnupiravir for prevention of Covid-19 infection.

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Coronavirus chronicle

Merck begins late-stage trial of experimental Covid-19 drug

Comments

Top Stories

MOST VIEWED

Features

Migrant workers face worse choices than building World Cup stadiums

Deeper and darker than you think: Illicit wildlife trade in Bangladesh

Why is it so difficult to correct NIDs, passports and certificates in Bangladesh?

We should embrace the circular economy before it's too late

More Videos from TBS

Asians ruling World Cup!

Black Panther: Wakanda Forever movie review

World Cup gossip with Srabonno Towhida episode 5

Munshiganj public suffer for new hospital building not opening

Most Read

How a 24-year-old greenhorn is 'blessed' with a Tk900cr loan

Central bank suspends Islami Bank's Tk9,135cr loan disbursement to 11 cos

Russian shipbuilders hiring Bangladeshis for the first time

32-storey ship set to carry Hajj pilgrims from Chattogram

Central bank to look into Islami Bank lending

Dhaka traffic comes to a standstill

Related News

Comments

MOST VIEWED

Related News

Most Read